Skip to main content

Table 3 Mean and median bleeding times (min)

From: Effects of concomitant use of prasugrel with edoxaban on bleeding time, pharmacodynamics, and pharmacokinetics of edoxaban in healthy elderly Japanese male subjects: a clinical pharmacology study

 

Group 1

30 mg edoxaban plus

2.5 mg prasugrel

Group 2

30 mg edoxaban plus

3.75 mg prasugrel

n = 12

n = 12

Baseline

 Mean (SD)

3.2 (0.8)

3.5 (1.1)

 Median (IQR)

3.0 (2.5–3.8)

3.5 (2.5–4.5)

Edoxaban administration

 Mean (SD)

3.5 (0.6)

4.7 (1.6)

 Median (IQR)

3.5 (3.0–4.0)

4.5 (3.3–6.0)

Edoxaban plus prasugrel administration

 Mean (SD)

5.4 (2.3)

7.3 (2.8)

 Median (IQR)

5.0 (3.5–7.3)

7.5 (5.5–10.0)

  1. SD standard deviation, IQR interquartile range